Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Dominguez

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Nature Communications|September 26, 2015
A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like familiesOriol Calvete, Paula Martinez, Pablo Garcia-Pavia, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 25, 2024
Incidence and predictors of sudden death in patients with cardiac amyloidosisFernando de Frutos, Giulia Saturi, Esther Gonzalez-Lopez, et al.
JACC. Cardiovascular Imaging|December 23, 2019
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac AmyloidosisMichele Boldrini, Francesco Cappelli, Liza Chacko, et al.
European Journal of Heart Failure|September 12, 2025
Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathySophie L V M Stroeks, Ping Wang, Marco Merlo, et al.
European Journal of Heart Failure|April 29, 2022
Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathyJesús G Mirelis, Luis Escobar-Lopez, Juan Pablo Ochoa, et al.
JACC. Heart Failure|October 19, 2024
Genetic Landscape of Patients With Dilated Cardiomyopathy and a Systemic Immune-Mediated DiseaseSophie L V M Stroeks, Michiel T H M Henkens, Fernando Dominguez, et al.
Circulation|December 2, 2017
International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)Constantinos O'Mahony, Fatima Jichi, Steve R Ommen, et al.
Journal of the American College of Cardiology|September 15, 2022
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated CardiomyopathyLuis Escobar-Lopez, Juan Pablo Ochoa, Ana Royuela, et al.
Circulation. Heart Failure|September 24, 2025
Sex Differences in Prognosis of Patients With Genetic Dilated CardiomyopathySophie L V M Stroeks, Marco Merlo, Nerea Mora-Ayestaran, et al.
Journal of the American College of Cardiology|July 11, 2020
Clinical Features and Natural History of PRKAG2 Variant Cardiac GlycogenosisAngela Lopez-Sainz, Fernando Dominguez, Luis Rocha Lopes, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Nature Communications|September 26, 2015
A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like familiesOriol Calvete, Paula Martinez, Pablo Garcia-Pavia, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 25, 2024
Incidence and predictors of sudden death in patients with cardiac amyloidosisFernando de Frutos, Giulia Saturi, Esther Gonzalez-Lopez, et al.
JACC. Cardiovascular Imaging|December 23, 2019
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac AmyloidosisMichele Boldrini, Francesco Cappelli, Liza Chacko, et al.
European Journal of Heart Failure|September 12, 2025
Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathySophie L V M Stroeks, Ping Wang, Marco Merlo, et al.
European Journal of Heart Failure|April 29, 2022
Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathyJesús G Mirelis, Luis Escobar-Lopez, Juan Pablo Ochoa, et al.
JACC. Heart Failure|October 19, 2024
Genetic Landscape of Patients With Dilated Cardiomyopathy and a Systemic Immune-Mediated DiseaseSophie L V M Stroeks, Michiel T H M Henkens, Fernando Dominguez, et al.
Circulation|December 2, 2017
International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)Constantinos O'Mahony, Fatima Jichi, Steve R Ommen, et al.
Journal of the American College of Cardiology|September 15, 2022
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated CardiomyopathyLuis Escobar-Lopez, Juan Pablo Ochoa, Ana Royuela, et al.
Circulation. Heart Failure|September 24, 2025
Sex Differences in Prognosis of Patients With Genetic Dilated CardiomyopathySophie L V M Stroeks, Marco Merlo, Nerea Mora-Ayestaran, et al.
Journal of the American College of Cardiology|July 11, 2020
Clinical Features and Natural History of PRKAG2 Variant Cardiac GlycogenosisAngela Lopez-Sainz, Fernando Dominguez, Luis Rocha Lopes, et al.
Pageof 8